€ 0.61
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Established in 1996, Arzneiwerk AG VIDA serves as a European supplier of pharmaceutical products, with a particular focus on novel and scarce medical treatments. In July 2024, the organization underwent a name change, adopting its current identity from its former designation as TELES Aktiengesellschaft. Its main operational hub is situated in Berlin, Germany.
Company Valuation
From both historical and forecast perspectives, the stock is overpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, of fair value on
Data is available to registered users only